Log In
Print this Print this

AEOL 20415

  Manage Alerts
Collapse Summary General Information
Company Aeolus Pharmaceuticals Inc.
DescriptionAnti-infective small molecule
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF); Treat infections in patients with cystic fibrosis (CF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today